It was an extremely busy week in the biotech sector, with several companies ... The acquisition adds to GSK’s growing portfolio in gastrointestinal (GI) cancers, including ongoing trials with ...

CEO J.D. Finley promised that the biotech is “in the midst of encouraging discussions that we believe will lead to pipeline expansion opportunities in high value indications in the GI space.” ...

Vaxcyte, Inc. (NASDAQ:PCVX), standing sixth among the best performing biotech stocks in 2024 ... VAX-PG for periodontal disease, and VAX-GI for Shigella. In Q3 2024, Vaxcyte, Inc. (NASDAQ:PCVX ...

After a rough start to the year, biotech stocks have been on an upswing, standing out in a difficult market for high-growth stocks. These notoriously volatile names have outperformed the broad ...

Investors' deep pessimism is actually bullish, and less regulatory constraint could fuel new drug approval and M&A Biotech is one of the U.S. stock market's most unloved sectors. But several ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Discover outperforming stocks and invest smarter with ...

Looking for the best biotech penny stocks? The most important innovation of the 1990s was the internet — today, it would be a vaccine for COVID-19. If these times have anything to say about it ...

We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where Gossamer Bio, Inc. (NASDAQ:GOSS) stands against other hot biotech stocks under $5.